Cargando…

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients

BACKGROUND: Colon adenocarcinoma (COAD) is the most common type of colon cancer. To date, however, the prognostic values of m6A RNA methylation-related long non-coding RNAs (lncRNAs) in COAD are largely unknown. MATERIALS AND METHODS: The m6A-related lncRNAs were identified from The Cancer Genome At...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Peiling, Liu, Guolong, Lu, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321625/ https://www.ncbi.nlm.nih.gov/pubmed/34336856 http://dx.doi.org/10.3389/fcell.2021.703629

Ejemplares similares

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

Dissecting the Role of N6-Methylandenosine-Related Long Non-coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2021)

Corrigendum: Dissecting the Role of N6-Methylandenosine-Related Long Non-Coding RNAs Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhang, Jinguo, et al.
Publicado: (2021)

Identification of N6-methylandenosine related lncRNA signatures for predicting the prognosis and therapy response in colorectal cancer patients
por: Li, Zhiyong, et al.
Publicado: (2022)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Identification of the Prognostic Significance of Somatic Mutation-Derived LncRNA Signatures of Genomic Instability in Lung Adenocarcinoma
por: Geng, Wei, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs in Tumor Microenvironment Are Potential Prognostic Biomarkers in Colon Cancer
por: Zhang, Hongliang, et al.
Publicado: (2021)

Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
por: Liu, Jing, et al.
Publicado: (2020)

Characterization of lncRNA-Perturbed TLR-Signaling Network Identifies Novel lncRNA Prognostic Biomarkers in Colorectal Cancer
por: Chu, Yanjie, et al.
Publicado: (2020)

Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma
por: Xu, Qiu-Shuang, et al.
Publicado: (2022)

N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Hu, YuHai, et al.
Publicado: (2021)

Development and Validation of Ferroptosis-Related LncRNA Biomarker in Bladder Carcinoma
por: Wang, Yiru, et al.
Publicado: (2022)

Comprehensive Analysis of an Individualized Immune-Related lncRNA Pair Signature in Gastric Cancer
por: Nie, Chuang, et al.
Publicado: (2022)

Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
por: Ding, Hongmei, et al.
Publicado: (2022)

Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
por: Xing, Zhe, et al.
Publicado: (2022)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Identification of lncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma
por: Zhang, Jiaqi, et al.
Publicado: (2020)

lncRNA Profiles Enable Prognosis Prediction and Subtyping for Esophageal Squamous Cell Carcinoma
por: Zhang, Shujun, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder Cancer
por: Zhang, Yuying, et al.
Publicado: (2021)

Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes
por: Feng, Chunyu, et al.
Publicado: (2022)

Constructing a novel signature and predicting the immune landscape of colon cancer using N6-methylandenosine-related lncRNAs
por: Wang, Yongfeng, et al.
Publicado: (2023)

Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives
por: Xie, Luhan, et al.
Publicado: (2021)

LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers
por: Yuan, Xin, et al.
Publicado: (2022)

Review of LINC00707: A Novel LncRNA and Promising Biomarker for Human Diseases
por: Yao, Qinfan, et al.
Publicado: (2022)

Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma
por: Zhang, Pei, et al.
Publicado: (2021)

Identification of N6-Methylandenosine-Related lncRNAs for Subtype Identification and Risk Stratification in Gastric Adenocarcinoma
por: Huang, Yuancheng, et al.
Publicado: (2021)

An Iron Metabolism-Related Gene Signature for the Prognosis of Colon Cancer
por: Yuan, Jing, et al.
Publicado: (2022)

Identification and Analysis of An Epigenetically Regulated Five-lncRNA Signature Associated With Outcome and Chemotherapy Response in Ovarian Cancer
por: Yang, Hao, et al.
Publicado: (2021)

Identification of an Immune-Related LncRNA Signature in Gastric Cancer to Predict Survival and Response to Immune Checkpoint Inhibitors
por: Ding, Zuoyou, et al.
Publicado: (2021)

Identification and Comprehensive Prognostic Analysis of a Novel Chemokine-Related lncRNA Signature and Immune Landscape in Gastric Cancer
por: Liang, Xiaolong, et al.
Publicado: (2022)

Integrative Analysis of DNA Methylation Data and Transcriptome Data Identified a DNA Methylation-Dysregulated Four-LncRNA Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma
por: Wang, Qiuxu, et al.
Publicado: (2021)

Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Li, Shuangquan, et al.
Publicado: (2022)

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Therapeutic Response of Gastric Cancer
por: Xiao, Shilang, et al.
Publicado: (2021)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2023)

M5C-Related lncRNA Predicts Lung Adenocarcinoma and Tumor Microenvironment Remodeling: Computational Biology and Basic Science
por: Bai, Ming, et al.
Publicado: (2022)

A lncRNA Perspective into (Re)Building the Heart
por: Frank, Stefan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q63rq2o8f576aa3svfvre604s5